Berger et al 1 conclude that "BNP levels are a strong, independent predictor of sudden death in patients with CHF." The predictive utility of a diagnostic test is usually expressed as predictive values, either positive predictive value (PPV, ratio of number of patients with true-positive test results to all patients with positive test results) or negative predictive value (NPV, ratio of number with true-negative test results to all patients with negative test results). 2 Using the data Berger et al 1 give on page 2394 for a BNP (B-type natriuretic peptide) cutpoint of 130 pg/mL, the PPV is 19% and the NPV is 99%. Thus, although a BNP level below 130 would allow the clinician to reassure a patient that sudden cardiac death (SCD) is very unlikely, putting implantable cardioverter-defibrillators (ICDs) in all patients with a BNP value above 130 pg/mL implies implanting 5 ICDs for every one that would discharge appropriately in the first 3 years. Many would regard this as financially infeasible. In addition, the prior probability of SCD in their study population is 13% (44/337), a number that is improved only to 19% by using BNP levels with a cutpoint of 130 pg/mL.
